Prevalence of HBV genotypes in Central and Eastern Europe

Journal of Medical Virology

Volumn 80, Issue 10, 2008, Pages 1707-1711

  Deterding, Katja ^a   Constantinescu, Ileana ^b   Nedelcu, Filofteia Daniela ^b   Gervain, Judit ^c   Némeček, Vratislav ^d   Srtunecky, Otakar ^d   Vince, Adriana ^e   Grgurevic, Ivica ^f   Bielawski, Krzysztof P ^g   Zalewska, Małgorzata ^h   Bock, Thomas ⁱ   Ambrozaitis, Arvydas ^j   Stanczak, Janusz ^k   Takács, Mária ^l   Chulanov, Vladimir ^m   Ślusarczyk, Janusz ⁿ   Dražd'áková, Marcela ^o   Wiegand, Johannes ^p   Cornberg, Markus ^a   Manns, Michael P ^a   Wedemeyer, Heiner ^a   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c Szent Gyorgy Hospital   (Hungary)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^e Croatia   (Croatia)

^f University of Zagreb   (Croatia)

^g UNIVERSITY OF GDA SK   (Poland)

^h WROCLAW MEDICAL UNIVERSITY   (Poland)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j VILNIUS UNIVERSITY   (Lithuania)

^k SP ZOZ Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS Warszawa   (Poland)

^l NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^m CENTRAL RESEARCH INSTITUTE OF EPIDEMIOLOGY   (Russian Federation)

ⁿ NATIONAL INSTITUTE OF HYGIENE   (Poland)

^o CHARLES UNIVERSITY   (Czech Republic)

^p UNIVERSITY OF LEIPZIG   (Germany)

more..

Author keywords

HBV genotype; Hepatitis B

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CROATIA; CZECH REPUBLIC; EASTERN EUROPE; GENOTYPE; GERMANY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUNGARY; HYBRIDIZATION; LITHUANIA; MAJOR CLINICAL STUDY; POLAND; PREVALENCE;

HEPATITIS B VIRUS;

EID: 50849125149     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21294     Document Type: Article

References (33)

1. Bielawski KP, Stalke P. 2005. Molecular epidemiology of chronic hepatitis B virus infection in northern Poland. J Clin Virol 34:S63-S69.
2. Bielawski KP, Dybikowska A, Lisowska-Charmuszko U, Stalke P, Gregorowicz K, Trocha H, Podhajska A. 2004. Distribution of HBV genotypes and mutants among hepatitis B infected patients from northern Poland. Int J Mol Med 14:301-304.
3. Bonino F, Marcellin P, Lau GK, Hadziyannis S, Jin R, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Brunetto MR, Farci P, Popescu M, McCloud P. 2007. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B. Gut 56:699-705.
4. Buti M. 2003. Hepatitis B virus genotypes. Gastroenterol Hepatol 26:260-262.
5. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65-73.
6. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS. 2003. Hepatitis B virus genotypes in the United States: Results of a nationwide study. Gastroenterology 125:444-451.
7. Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP. 2007. Prophylaxis, diagnosis and therapy of hepatitis-B-virus-(HBV-)infection: Upgrade of the guideline, AWMF-Register 021/011. Z Gastroenterol 45:525-574.
8. Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, Haussinger D. 2005. Response to interferon alfa is hepatitis B virus genotype dependent: Genotype A is more sensitive to interferon than genotype D. Gut 54:1009-1013.
9. Fung SK, Lok AS. 2004. Hepatitis B virus genotypes: Do they play a role in the outcome of HBV infection? Hepatology 40:790-792.
10. Ganne-Carrie N, Williams V, Kaddouri H, Trinchet JC, Dziri-Mendil S, Alloui C, Hawajri NA, Deny P, Beaugrand M, Gordien E. 2006. Significance of hepatitis B virus genotypes A to E in a cohort of patients with chronic hepatitis B in the Seine Saint Denis District of Paris (France). J Med Virol 78:335-340.
11. Gjorup IE, Smith E, Borgwardt L, Skinhoj P. 2003. Twenty-year survey of the epidemiology of hepatitis B in Denmark: Effect of immigration. Scand J Infect Dis 35:260-264.
12. Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. 2004. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: Implications for immunisation policy. J Clin Virol 29:211-220.
13. Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Niesters HG, Zondervan P, Hansen B, Schalm SW. 2005. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitisB: Arandomised trial. Lancet 365:123-129.
14. Kao JH, Chen DS. 2005. HBV genotypes and outcome of HBV infection. Hepatology 41:216.
15. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N. 2005. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352:2682-2695.
16. Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. 1993. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: Possible contribution of a single nucleotide in the precore region. J Virol 67:5402-5410.
17. Liu CJ, Kao JH, Chen DS. 2005. Therapeutic implications of hepatitis B virus genotypes. Liver Int 25:1097-1107.
18. Lurie Y, Manns MP, Gish RG, Chang TT, Yurdaydin C, Lai CL, Shouval D, Brown RS, Apelian D, Fernandes L, Klesczewski K, Cross A, Wilber R. 2005. The efficacy of entecavir is similar regardless of disease-related baseline subgroups in treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B. J Hepatol 42:184.
19. Marschall T, Kramer A, Prufer-Kramer L, Mikolajczyk R, Kretzschmar M. 2005. Does migration from high and intermediate endemic regions increase the prevalence of hepatitis B infection in Germany? Dtsch Med Wochenschr 130:2753-2758.
20. Medici MC, Aloisi A, Martinelli M, Abelli LA, Casula F, Valcavi P, Dettori G, Chezzi C. 2006. HBV genotypes and antiviral-resistant variants in HBV infected subjects in Northern Italy. New Microbiol 29:63-67.
21. Nemecek V, Strunecky O. 2004. Hepatitis B virus (HBV) genotypes in the Czech Republic. Epidemiol Mikrobiol Imunol 53:55-61.
22. Niederau C, Fischer C, Kautz A. 2007. Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients. Socio-economical aspects in hepatitis B. Z Gastroenterol 45:355-368.
23. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
24. Orito E, Mizokami M. 2003. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Intervirology 46:408-412.
25. Qutub MO, Germer JJ, Rebers SP, Mandrekar JN, Beld MG, Yao JD. 2006. Simplified PCR protocols for INNO-LiPA HBV Genotyping and INNO-LiPA HBV PreCore assays. J Clin Virol 37:218-221.
26. Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J. 2002. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123:1848-1856.
27. Simmonds P, Midgley S. 2005. Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 79:15467-15476.
28. Slusarczyk J, Bialkowska J, Bucholc B, Wiatrzyk A, Gorska P, Jablkowski M. 2006. HBV genotypes among patients with chronic hepatitis B in the area of central Poland. Przegl Epidemiol 60:555-561.
29. Song IH, Binh VQ, Duy DN, Juliger S, Bock TC, Luty AJ, Kremsner PG, Kun JF. 2003. Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients. Mutat Res 522:119-125.
30. Toan NL, Song IH, Kremsner PG, Duy DN, Binh VQ, Koeberlein B, Kaiser S, Kandolf R, Torresi J, Bock CT. 2006. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology 43:1375-1384.
31. Westland C, Delaney W, Yang H, Chen SS, Marcellin P, Hadziyannis S, Gish R, Fry J, Brosgart C, Gibbs C, Miller M, Xiong S. 2003. Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxill. Gastroenterology 125:107-116.
32. Wiegand J, Hasencleves D, Tillmann HL. 2007. Should treatment of Hepatitis B depend on HBV genotypes? A hypothesis generated from an explorative analysis of published evidence. Hepatology 44:564A-565A.
33. Zalewska M, Domagala M, Simon K, Gladysz A. 2005. Hepatitis B virus genotypes and the response to lamivudine therapy. Pol Arch Med Wewn 114:1190-1199.